What is the price target for MOR stock?
12 analysts have analysed MOR and the average price target is 5.06 USD. This implies a price decrease of -73.33% is expected in the next year compared to the current price of 18.96.
MorphoSys AG (MOR) Forecast, Price Target & Analyst Ratings
NASDAQ:MOR • US6177602025
Current stock price
18.96 USD
+0.45 (+2.43%)
At close:
18.96 USD
0 (0%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MorphoSys AG (MOR).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Aug 29, 2024
- Period
- Q2 / 2024
- EPS Estimate
- -€0.29
- Revenue Estimate
- 45.588M
Price Target Details & History
Consensus Price Target and Range
Mean target
$6.70
Upside
-64.67%
From current price of $18.96 to mean target of $6.70, Based on 12 analyst forecasts
Low
$2.67
Median
$3.50
High
$18.01
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
12 Wall Street analysts provided a forecast for the next 12 months for MOR. The average price target is 5.06 USD. This implies a price decrease of -73.33% is expected in the next year compared to the current price of 18.96.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
70.00%
MOR was analyzed by 12 analysts. The buy percentage consensus is at 70. So analysts seem to be have mildly positive about MOR.
In the previous month the buy percentage consensus was at a similar level.
MOR was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-03-14 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2024-02-05 | Wells Fargo | Reiterate | Overweight -> Overweight |
| 2024-01-19 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2024-01-16 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2023-12-15 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2023-12-05 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-11-22 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-11-21 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-10-13 | Morgan Stanley | Upgrade | Underweight -> Overweight |
| 2023-09-15 | Goldman Sachs | Upgrade | Sell -> Neutral |
| 2023-06-22 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-06-16 | Wells Fargo | Initiate | Overweight |
| 2023-06-16 | JP Morgan | Upgrade | Underweight -> Overweight |
| 2023-01-03 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2022-11-18 | JMP Securities | Maintains | Market Outperform |
| 2022-01-14 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2021-08-06 | Deutsche Bank | Initiate | |
| 2021-08-04 | JPMorgan Chase | Initiate | |
| 2021-07-29 | Berenberg Bank | Initiate | |
| 2021-07-19 | Barclays | Initiate | |
| 2021-07-10 | Morgan Stanley | Initiate | |
| 2021-07-09 | Morgan Stanley | Initiate | |
| 2021-07-05 | Stifel Nicolaus | Initiate | |
| 2021-06-16 | Berenberg Bank | Initiate | Buy |
| 2021-06-14 | JPMorgan Chase | Initiate | Neutral |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Aug 29, 2024
- Period
- Q2 / 2024
- EPS Estimate
- -€0.29
- Revenue Estimate
- 45.588M
- Revenue Q2Q
- -14.25%
- EPS Q2Q
- 46.98%
- Number of Analysts
- 4
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.71%
EPS (1 Month)
3.95%
EPS (3 Months)
2.22%
Next Earnings Summary
MOR is expected to report earnings on 8/29/2024. The consensus EPS estimate for the next earnings is -0.29 USD and the consensus revenue estimate is 45.59M USD.
The next earnings revenue estimate has been revised upward by 0.71% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 179.612M -45.19% | 278.267M 54.93% | 238.278M -14.37% | 234.49M -1.59% | 307.62M 31.19% | 449.11M 46.00% | 730.22M 62.59% | 1.027B 40.64% | 920.9M -10.33% | 1.063B 15.43% | |
| EBITDA YoY % growth | -265.863M -1,229.09% | -201.918M 24.05% | -222.37M -10.13% | -158.451M 28.74% | -84.843M 46.45% | 2.134M 102.52% | -6.199M -390.48% | N/A | N/A | N/A | |
| EBIT YoY % growth | -275.954M -1,913.43% | -212.454M 23.01% | -232.905M -9.63% | -190.346M 18.27% | -112.088M 41.11% | -16.182M 85.56% | 289.88M 1,891.40% | 411.77M 42.05% | -95.613M -123.22% | -34.219M 64.21% | |
| Operating Margin | -153.64% | -76.35% | -97.75% | -81.17% | -36.44% | -3.60% | 39.70% | 40.09% | -10.38% | -3.22% | |
| EPS YoY % growth | -3.85 -873.87% | -1.10 71.30% | -1.38 -25.11% | -1.09 20.86% | -0.84 23.51% | -0.30 64.40% | -0.37 -24.65% | 1.14 407.42% | 0.92 -19.24% | 1.31 42.08% |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.29 46.98% | -0.25 70.86% | -0.25 -167.91% | -0.17 91.83% |
| Revenue Q2Q % growth | 45.588M -14.25% | 47.304M -25.83% | 48.73M -17.43% | 36.287M 31.77% |
| EBITDA Q2Q % growth | -12.666M 71.68% | -15.696M 55.24% | -20.746M 71.11% | N/A |
| EBIT Q2Q % growth | -29.019M 42.51% | -27.249M 37.42% | -26.161M 68.23% | -29.517M 88.82% |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
21.29%
EPS Next 5 Year
23.09%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
22.79%
Revenue Next 5 Year
33.46%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
26.15%
EBIT Next 5 Year
18.59%
MorphoSys AG / MOR Forecast FAQ
When does MorphoSys AG (MOR) report earnings?
MorphoSys AG (MOR) will report earnings on 2024-08-29, after the market close.
What are the consensus estimates for MOR stock next earnings?
The consensus EPS estimate for the next earnings of MorphoSys AG (MOR) is -0.29 USD and the consensus revenue estimate is 45.59M USD.
What is the number of analysts for MOR stock?
The number of analysts covering MorphoSys AG (MOR) is 12.